Prognosis for different patterns of distant metastases in patients with uterine cervical cancer: a population-based analysis

Yiran Zhang, Ying Guo, Xin-Zi Zhou, Xuena Wang, Xiaofei WangJournal of Cancer 2020 · DOI

Abstract

Uterine cervical cancer (UCC) remains a major cause of cancer-related mortality among women. This study investigates the patterns of distant metastases and prognostic factors in patients with FIGO stage IVB UCC. Using data from the Surveillance, Epidemiology, and End Results (SEER) database (n=1,448) and a validation cohort from Tianjin First Central Hospital (n=227), researchers analyzed survival outcomes based on the number and location of metastatic sites. Results showed that 30.8% of patients had multiple metastatic sites, which correlated with significantly worse survival (5 months) compared to single-site metastasis (8 months). Key prognostic factors included age, race, tumor grade, and the number of metastatic sites.

Introduction: The Challenge of Advanced UCC

While early detection has improved outcomes for many, approximately 13% of uterine cervical cancer (UCC) cases are diagnosed at FIGO Stage IVB, where the disease has spread to distant organs. Historically, research on advanced UCC has been limited by small cohorts or a narrow focus on specific metastatic sites. This population-based study provides a comprehensive analysis of how different metastatic patterns—specifically the number and combination of involved organs—impact patient prognosis.

Methods and Study Design

The researchers utilized a retrospective cohort design across two distinct populations:

  1. Study Group: 1,448 patients from the SEER database (2010–2016), representing a broad US population.
  2. Validation Group: 227 patients from Tianjin First Central Hospital (2004–2017) to ensure the findings' generalizability.
Flowchart of patient selection from the SEER database showing the inclusion and exclusion criteria.

The study focused on four primary metastatic sites: bone, brain, liver, and lung. Survival was estimated using Kaplan-Meier analysis, and independent prognostic factors were identified via Cox proportional hazard regression.

Key Insights: Patterns of Spread and Survival

The study revealed a clear correlation between the extent of metastatic spread and patient survival. Approximately 70% of patients presented with a single metastatic site, with the lung being the most frequent destination (65.0% of the total group).

A significant "survival gap" was observed:

  • Single-site metastasis: Median overall survival (OS) of 8 months.
  • Multiple-site metastasis: Median OS of 5 months.

The risk of death increased by approximately 65-68% for patients with two or more metastatic sites compared to those with only one. Furthermore, the specific combination of sites mattered; for instance, patients with brain involvement generally faced a poorer prognosis than those with isolated bone metastases.

Survival curves for patients with different combinations of two metastatic sites, illustrating varying prognoses.

Prognostic Factors

Multivariate analysis identified several independent risk factors for poor prognosis across the entire cohort:

  • Demographics: Age ≥ 65 years and Black race.
  • Clinical Characteristics: Higher tumor grade and higher T-stage (primary tumor size/extent).
  • Metastatic Burden: Presence of two or more metastatic sites.

Interestingly, the relevance of these factors shifted depending on the metastatic pattern. For patients with two metastatic sites, insurance status and surgical history emerged as significant predictors, whereas race and T-stage were more dominant in single-site cases.

Limitations and Future Directions

The study's reliance on the SEER database introduces certain limitations, such as the lack of detailed data on distant lymph node involvement, peritoneal spread, and specific treatment regimens like chemotherapy or radiotherapy. Additionally, biological markers such as HPV status were not included. Future research integrating genomic data and more granular treatment records is necessary to further refine these prognostic models and guide personalized treatment strategies for advanced UCC.

Summary updated

Abstract

<b>Background</b>: Uterine cervical cancer (UCC) is a common malignant tumor in women. We conducted this work to provide a though description on the patterns of distant metastases and to investigate the relevant factors for prognosis of UCC patients based on a large population. <b>Patients and methods</b>: UCC patients with FIGO stage IVB, being the study group, were identified from the Surveillance, Epidemiology, and End Result (SEER) database from 2010 to 2016. UCC patients with same inclusion criteria, being validation group, were identified from Tianjin First Central Hospital from 2004 to 2017. Patterns of distant metastases were described according to the number of metastatic sites. Survival of different patterns were calculated and prognostic factors were investigated by Cox hazard regression analysis. <b>Results</b>: Distant metastases were recorded in 1448 UCC patients among whom 295 patients (30.8%) developed metastases in two or more organs. Compared with the median OS of 8 (95%CI, 7.07-8.93) months in the patients with the single site, worse survival of 5 (95%CI, 4.29-5.71) months was noticed in the patients with multiple metastases. Age ≥ 65 years, black race, higher grade, higher T stage and more metastatic sites were proved to be the prognostic factors for all the patients in the advanced stage and the results were partly validated in the validation cohort. Moreover, black race and higher T-stage for the patients with the single metastatic sites and age ≥ 65, uninsured status, surgical treatment and metastatic pattern for the patients with two metastatic sites were prognostic factors. No independent factor was found in patients with three or more metastases. <b>Conclusion</b>: Around 70% of the patients suffered one site distant metastasis in UCC patients with IVB stage while 30% with multiple metastases and a significantly reduced survival. Different survivals and prognostic factors were noticed for different patterns of distant metastases.
BibTeX
@article{zhang2020prognosis,
  author = {Yiran Zhang and Ying Guo and Xin-Zi Zhou and Xuena Wang and Xiaofei Wang},
  title = {{Prognosis for different patterns of distant metastases in patients with uterine cervical cancer: a population-based analysis}},
  journal = {Journal of Cancer},
  year = {2020},
  doi = {10.7150/jca.37390},
}
Figure